Pol-Henry Bonte

Venture Capital Brussels, Belgium ·Founded 2015

Overview

The Innovation Fund is a venture capital firm based in Schaerbeek, Belgium, established in 2015. It targets investments across health and science sectors, including healthcare devices and services, life sciences, material science and biosciences, process technology, hygiene and cosmetology, recycling technology, and B2B and commercial services. The firm focuses on growth equity investments, primarily in the Seed to Growth stages, with a geographical focus on Belgium, Benelux, Europe, France, and Switzerland. The industries of interest include Biotechnology, CleanTech, Healthcare, Medical Devices, Industrial Automation, Advanced Materials, Chemical, Cosmetics, Recycling, Nanotechnology, Biosciences, and Plastics and Rubber Manufacturing. Investment sizes range from €1 million to €10 million. The firm's investment strategy emphasizes sectors such as Biotechnology, CleanTech, Healthcare, Medical Devices, Industrial Automation, Advanced Materials, Chemical, Cosmetics, Recycling, Nanotechnology, Biosciences, and Plastics and Rubber Manufacturing. The firm has a track record of supporting companies like X4C, which develops innovative coating solutions for biotechnology applications, and Proceedix, which offers a platform for managing enterprise procedures and inspections in a paperless and mobile manner. The Innovation Fund's portfolio reflects its commitment to fostering innovation and growth in these diverse sectors. The Innovation Fund's investment philosophy centers on supporting innovative companies that have the potential to make a significant impact in their respective industries. By providing growth equity, the firm aims to enable these companies to scale their operations and achieve their strategic objectives. The firm's focus on sectors such as Biotechnology, CleanTech, Healthcare, Medical Devices, Industrial Automation, Advanced Materials, Chemical, Cosmetics, Recycling, Nanotechnology, Biosciences, and Plastics and Rubber Manufacturing underscores its dedication to advancing technologies and solutions that address critical challenges in health, sustainability, and industrial efficiency. Through its investments, the Innovation Fund seeks to contribute to the development of a more sustainable and technologically advanced future.

Investment Focus

  • Innovative companies with high growth potential
  • Focus on health and science sectors
  • Alignment with the firm's investment philosophy

Portfolio Companies

ProceedixX4C

Get the full list of 54,000+ investors

Pol-Henry Bonte and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Pol-Henry Bonte

What sectors does Pol-Henry Bonte invest in?

Pol-Henry Bonte invests in Healthcare, Medical Devices, Biotechnology, Cleantech, Biosciences and Nanotechnology, and is based in Brussels, Belgium. Pol-Henry Bonte is listed as a venture capital in the ConnectSafely investor database.

What stage does Pol-Henry Bonte invest at?

Pol-Henry Bonte backs companies at Seed, Series A, Series B and Growth, writing cheques of 1M - 10M.

Which regions does Pol-Henry Bonte invest in?

Pol-Henry Bonte invests across Europe, France, Switzerland, Belgium and Benelux.

What companies has Pol-Henry Bonte invested in?

Pol-Henry Bonte's portfolio includes Proceedix and X4C.

Last updated · Source: ConnectSafely investor database